Prima BioMed - 48 Year Dividend History | IMMP

Historical dividend payout and yield for Prima BioMed (IMMP) since 1971. The current TTM dividend payout for Prima BioMed (IMMP) as of May 20, 2019 is $0.00. The current dividend yield for Prima BioMed as of May 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.066B $0.006B
Immutep Limited is a biotechnology company. It engaged in developing novel immunotherapy treatments for cancer and autoimmune disease. The company's product pipeline consists of eftilagimod alpha, IMP731, IMP701 and IMP761 which are in clinical stage. It operates primarily in Europe, Australia and the U.S. Immutep Limited, formerly known as Prima BioMed Ltd, is headquartered in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $103.634B 11.72
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.478B 51.02